Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?

被引：0
作者：
Bonfil, R. D. [1 ,2 ,3 ]
Fridman, R. [2 ,3 ]
Mobashery, S. [4 ,5 ]
Cher, M. L. [1 ,2 ,3 ]
机构：
[1] Wayne State Univ, Sch Med, Dept Urol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA
[3] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[4] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
[5] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA
来源：
CURRENT ONCOLOGY | 2008年 / 15卷 / 04期
关键词：
matrix metalloproteinases; prostate cancer; bone metastasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：188 / 192
页数：5
相关论文
共 40 条
[1]   Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration [J].
Bair, EL ;
Chen, ML ;
McDaniel, K ;
Sekiguchi, K ;
Cress, AE ;
Nagle, RB ;
Bowden, GT .
NEOPLASIA, 2005, 7 (04) :380-389
[2]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[3]   Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis [J].
Bonfil, R. Daniel ;
Chinni, Sreenivasa ;
Fridman, Rafael ;
Kim, Hyeong-Reh ;
Cher, Michael L. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) :407-411
[4]   Prostate cancer-associated membrane type 1-matrix metalloproteinase - A pivotal role in bone response and intraosseous tumor growth [J].
Bonfil, R. Daniel ;
Dong, Zhong ;
Trindade Filho, J. Carlos ;
Sabbota, Aaron ;
Osenkowski, Pamela ;
Nabha, Sanaa ;
Yamamoto, Hamilto ;
Chinni, Sreenivasa R. ;
Zhao, Huiren ;
Mobashery, Shahriar ;
Vessella, Robert L. ;
Fridman, Rafael ;
Cher, Michael L. .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (06) :2100-2111
[5]   Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor [J].
Bonfil, RD ;
Sabbota, A ;
Nabha, S ;
Bernardo, MM ;
Dong, Z ;
Meng, H ;
Yamamoto, H ;
Chinni, SR ;
Lim, IT ;
Chang, M ;
Filetti, LC ;
Mobashery, S ;
Cher, ML ;
Fridman, R .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) :2721-2726
[6]   Potent and selective mechanism-based inhibition of gelatinases [J].
Brown, S ;
Bernardo, MM ;
Li, ZH ;
Kotra, LP ;
Tanaka, Y ;
Fridman, R ;
Mobashery, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (28) :6799-6800
[7]   Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients [J].
Bubendorf, L ;
Schöpfer, A ;
Wagner, U ;
Sauter, G ;
Moch, H ;
Willi, N ;
Gasser, TC ;
Mihatsch, MJ .
HUMAN PATHOLOGY, 2000, 31 (05) :578-583
[8]   Membrane type I-matrix metalloproteinase promotes human prostate cancer invasion and metastasis [J].
Cao, J ;
Chiarelli, C ;
Kozarekar, P ;
Adler, HL .
THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) :770-778
[9]  
Cardillo MR, 2006, ANTICANCER RES, V26, P973
[10]   Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications [J].
Chung, LWK .
CANCER, 2003, 97 (03) :772-778
1234